Works matching IS 00070963 AND DT 2022 AND VI 186 AND IP 3

Results: 70

Issue Information.

Published in:: British Journal of Dermatology, 2022, v. 186, n. 3, p. i, doi. 10.1111/bjd.21664
Publication type:: Article

News and Notices.

Published in:: British Journal of Dermatology, 2022, v. 186, n. 3, p. 595, doi. 10.1111/bjd.21052
Publication type:: Article

Corrigendum.

Published in:: British Journal of Dermatology, 2022, v. 186, n. 3, p. 597, doi. 10.1111/bjd.21040
Publication type:: Article

Corrigendum.

Published in:: British Journal of Dermatology, 2022, v. 186, n. 3, p. 596, doi. 10.1111/bjd.21039
Publication type:: Article

Obituary: Dr Rodney Dawber, 1938–2021.

Published in:: 2022
Publication type:: Obituary

英国皮肤科医师协会慢性荨麻疹患者管理指南.

Published in:: British Journal of Dermatology, 2022, v. 186, n. 3, p. e133, doi. 10.1111/bjd.21006
Publication type:: Article

深入了解荷兰诊断为基底细胞癌的患者数量以及对未来患者数量的估计.

Published in:: British Journal of Dermatology, 2022, v. 186, n. 3, p. e132, doi. 10.1111/bjd.21005
Publication type:: Article

efgartigimod 作为天疱疮新疗法的研究.

Published in:: British Journal of Dermatology, 2022, v. 186, n. 3, p. e131, doi. 10.1111/bjd.21004
Publication type:: Article

中重度斑块型银屑病患者长期使用瑞莎珠单抗治疗的安全性.

Published in:: British Journal of Dermatology, 2022, v. 186, n. 3, p. e130, doi. 10.1111/bjd.21003
Publication type:: Article

有关简单快速地测量特应性皮炎严重程度的方法建议.

Published in:: British Journal of Dermatology, 2022, v. 186, n. 3, p. e129, doi. 10.1111/bjd.21002
Publication type:: Article

充分了解粘蛋白在皮肤中的作用.

Published in:: British Journal of Dermatology, 2022, v. 186, n. 3, p. e128, doi. 10.1111/bjd.21001
Publication type:: Article

116 名法国患者的 VEXAS 综合征回顾.

Published in:: British Journal of Dermatology, 2022, v. 186, n. 3, p. e127, doi. 10.1111/bjd.21000
Publication type:: Article

丝聚蛋白基因突变与婴儿湿疹.

Published in:: British Journal of Dermatology, 2022, v. 186, n. 3, p. e126, doi. 10.1111/bjd.20999
Publication type:: Article

便于充分了解炎症后色素沉着的模型.

Published in:: British Journal of Dermatology, 2022, v. 186, n. 3, p. e125, doi. 10.1111/bjd.20998
Publication type:: Article

注射型曲罗芦单抗为重度特应性皮炎患者带来新希望.

Published in:: British Journal of Dermatology, 2022, v. 186, n. 3, p. e124, doi. 10.1111/bjd.20997
Publication type:: Article

用于衡量皮肤病患者健康相关生活质量的不同问卷的比较.

Published in:: British Journal of Dermatology, 2022, v. 186, n. 3, p. e123, doi. 10.1111/bjd.20996
Publication type:: Article

British Association of Dermatologists guidelines for the management of people with chronic urticaria.

Published in:: British Journal of Dermatology, 2022, v. 186, n. 3, p. e122, doi. 10.1111/bjd.20995
Publication type:: Article

Insight into the number of patients diagnosed with basal cell carcinoma in the Netherlands and an estimation of future numbers.

Published in:: British Journal of Dermatology, 2022, v. 186, n. 3, p. e121, doi. 10.1111/bjd.20994
Publication type:: Article

Study of efgartigimod as a new treatment for pemphigus.

Published in:: British Journal of Dermatology, 2022, v. 186, n. 3, p. e120, doi. 10.1111/bjd.20993
Publication type:: Article

Safety of long‐term treatment with risankizumab in patients with moderate‐to‐severe plaque psoriasis.

Published in:: British Journal of Dermatology, 2022, v. 186, n. 3, p. e119, doi. 10.1111/bjd.20992
Publication type:: Article

Proposal for an easy and rapid way of measuring atopic dermatitis severity.

Published in:: British Journal of Dermatology, 2022, v. 186, n. 3, p. e117, doi. 10.1111/bjd.20991
Publication type:: Article

Greater understanding about the role of mucin proteins in the skin.

Published in:: British Journal of Dermatology, 2022, v. 186, n. 3, p. e116, doi. 10.1111/bjd.20990
Publication type:: Article

A review of VEXAS syndrome in 116 French patients.

Published in:: British Journal of Dermatology, 2022, v. 186, n. 3, p. e115, doi. 10.1111/bjd.20989
Publication type:: Article

Filaggrin gene mutations and eczema in infants.

Published in:: British Journal of Dermatology, 2022, v. 186, n. 3, p. e114, doi. 10.1111/bjd.20988
Publication type:: Article

A model to understand postinflammatory hyperpigmentation better.

Published in:: British Journal of Dermatology, 2022, v. 186, n. 3, p. e113, doi. 10.1111/bjd.20987
Publication type:: Article

Injectable tralokinumab gives new hope to patients with severe atopic dermatitis.

Published in:: British Journal of Dermatology, 2022, v. 186, n. 3, p. e112, doi. 10.1111/bjd.20986
Publication type:: Article

A comparison of the different questionnaires used to measure health‐related quality of life in patients with dermatological conditions.

Published in:: British Journal of Dermatology, 2022, v. 186, n. 3, p. e111, doi. 10.1111/bjd.20985
Publication type:: Article

Editor's Choice.

Published in:: British Journal of Dermatology, 2022, v. 186, n. 3, p. xi, doi. 10.1111/bjd.20984
Publication type:: Article

From FOS fusions to somatic mutations in the MAPK pathway, heterogeneous genetic abnormalities cause distinct pathophysiology among subsets of epithelioid haemangiomas.

Published in:

British Journal of Dermatology, 2022, v. 186, n. 3, p. 393, doi. 10.1111/bjd.20952

By:

Tan, W.;
Nelson, J.S.

Publication type:

Article

Easy assessment tool for disease severity of atopic dermatitis in clinical practice.

Published in:: British Journal of Dermatology, 2022, v. 186, n. 3, p. 397, doi. 10.1111/bjd.20951
Publication type:: Article

Working towards a better understanding of VEXAS syndrome.

Published in:

British Journal of Dermatology, 2022, v. 186, n. 3, p. 392, doi. 10.1111/bjd.20949

By:

Nicholson, L.T.;
Madigan, L.M.

Publication type:

Article

Questionnaire use depends on the study goal, target group and phase of the condition.

Published in:: British Journal of Dermatology, 2022, v. 186, n. 3, p. 395, doi. 10.1111/bjd.20948
Publication type:: Article

Safety in numbers: risankizumab for moderate‐to‐severe psoriasis.

Published in:

British Journal of Dermatology, 2022, v. 186, n. 3, p. 394, doi. 10.1111/bjd.20947

By:

Mirali, S.;
Fabusiwa, K.;
Linos, E.

Publication type:

Article

Atopic dermatitis: filaggrin and skin barrier dysfunction.

Published in:: British Journal of Dermatology, 2022, v. 186, n. 3, p. 396, doi. 10.1111/bjd.20946
Publication type:: Article

Ocular conjunctivitis in biological therapies for atopic dermatitis.

Published in:: British Journal of Dermatology, 2022, v. 186, n. 3, p. 391, doi. 10.1111/bjd.20945
Publication type:: Article

Targeting the neonatal Fc receptor in pemphigus: safety first.

Published in:

British Journal of Dermatology, 2022, v. 186, n. 3, p. 389, doi. 10.1111/bjd.20939

By:

Micevic, G.;
Lo, S.N.;
Rajan, N.

Publication type:

Article

Postinflammatory hyperpigmentation and erythema: new insights into the pathogenesis.

Published in:

British Journal of Dermatology, 2022, v. 186, n. 3, p. 390, doi. 10.1111/bjd.20938

By:

Concha, J.S.S.;
Afarideh, M.;
Werth, V.P.

Publication type:

Article

Transcriptomic changes during stage progression of mycosis fungoides: from translational analyses to their potential clinical implications.

Published in:

British Journal of Dermatology, 2022, v. 186, n. 3, p. 387, doi. 10.1111/bjd.20895

By:

Dobos, G.;
Assaf, C.

Publication type:

Article

British Association of Dermatologists guidelines for the management of people with chronic urticaria 2021*.

Published in:

British Journal of Dermatology, 2022, v. 186, n. 3, p. 398, doi. 10.1111/bjd.20892

By:

Sabroe, R.A.;
Lawlor, F.;
Grattan, C.E.H.;
Ardern‐Jones, M.R.;
Bewley, A.;
Campbell, L.;
Flohr, C.;
Leslie, T.A.;
Marsland, A.M.;
Ogg, G.;
Sewell, W.A.C.;
Hashme, M.;
Exton, L.S.;
Mohd Mustapa, M.F.;
Ezejimofor, M.C.

Publication type:

Article

National Institute for Health and Care Excellence (NICE) acne guideline: what's the latest for dermatologists?

Published in:

British Journal of Dermatology, 2022, v. 186, n. 3, p. 426, doi. 10.1111/bjd.20888

By:

Layton, A.M.;
McDonald, B.S.;
Mohd Mustapa, M.F.;
Levell, N.J.

Publication type:

Article

Early tumour response assessment may avoid serious immune‐related adverse events in nivolumab and ipilimumab combination therapy for stage IV melanoma.

Published in:

British Journal of Dermatology, 2022, v. 186, n. 3, p. 587, doi. 10.1111/bjd.20879

By:

Maeda, T.;
Hiura, A.;
Uehara, J.;
Toyoshima, R.;
Nakagawa, T.;
Yoshino, K.

Publication type:

Article

Modulating mucins makes melanin.

Published in:

British Journal of Dermatology, 2022, v. 186, n. 3, p. 388, doi. 10.1111/bjd.20877

By:

Casalou, C.;
Tobin, D.J.

Publication type:

Article

Bullous Sweet syndrome following SARS‐CoV‐2 Oxford AstraZeneca vaccine.

Published in:

British Journal of Dermatology, 2022, v. 186, n. 3, p. e110, doi. 10.1111/bjd.20876

By:

Žagar, T.;
Hlača, N.;
Brajac, I.;
Prpić‐Massari, L.;
Peternel, S.;
Kaštelan, M.

Publication type:

Article

IGAxBSA composite for assessing disease severity and response in patients with atopic dermatitis*.

Published in:

British Journal of Dermatology, 2022, v. 186, n. 3, p. 496, doi. 10.1111/bjd.20872

By:

Paller, A.S.;
Tan, J.K.L.;
Bagel, J.;
Rossi, A.B.;
Shumel, B.;
Zhang, H.;
Abramova, A.

Publication type:

Article

A nationwide study of the incidence and trends of first and multiple basal cell carcinomas in the Netherlands and prediction of future incidence*.

Published in:

British Journal of Dermatology, 2022, v. 186, n. 3, p. 476, doi. 10.1111/bjd.20871

By:

Schreuder, K.;
Hollestein, L.;
Nijsten, T.E.C.;
Wakkee, M.;
Louwman, M.W.J.

Publication type:

Article

Perineal cutaneous basal cell carcinomas in patients with familial seronegative coeliac disease: report of three cases.

Published in:

British Journal of Dermatology, 2022, v. 186, n. 3, p. 588, doi. 10.1111/bjd.20870

By:

Lambert, W.C.;
Sy, C.B.;
Madari, A.P.;
Schwartz, R.A.

Publication type:

Article

Cutaneous epithelioid haemangiomas show somatic mutations in the mitogen‐activated protein kinase pathway.

Published in:

British Journal of Dermatology, 2022, v. 186, n. 3, p. 553, doi. 10.1111/bjd.20869

By:

Maurus, K.;
Kosnopfel, C.;
Kneitz, H.;
Appenzeller, S.;
Schrama, D.;
Glutsch, V.;
Roth, S.;
Gerhard‐Hartmann, E.;
Rosenfeldt, M.;
Möhrmann, L.;
Fröhlich, M.;
Hübschmann, D.;
Stenzinger, A.;
Glimm, H.;
Fröhling, S.;
Goebeler, M.;
Rosenwald, A.;
Kutzner, H.;
Schilling, B.

Publication type:

Article

Validation of generalized drug‐related rash diagnoses using International Classification of Diseases 9th and 10th Revision codes.

Published in:

British Journal of Dermatology, 2022, v. 186, n. 3, p. 583, doi. 10.1111/bjd.20868

By:

Goldenberg, M.;
Amigo, M.;
Krishna, S.G.;
Milani‐Nejad, N.;
Trinidad, J.C.;
Kaffenberger, B.H.

Publication type:

Article

Unfolding the worldwide incidence of bullous pemphigoid: what are we missing?

Published in:

British Journal of Dermatology, 2022, v. 186, n. 3, p. 386, doi. 10.1111/bjd.20838

By:

Aoki, V.;
Miyamoto, D.

Publication type:

Article

Response to 'A clinical and biological review of keratoacanthoma': reply from authors.

Published in:

British Journal of Dermatology, 2022, v. 186, n. 3, p. 592, doi. 10.1111/bjd.20835

By:

Tisack, A.;
Fotouhi, A.;
Fidai, C.;
Friedman, B.J.;
Ozog, D.;
Veenstra, J.

Publication type:

Article